5 Key Takeaways

• 1

  Dry eye disease is a common challenge for cataract surgery patients, impacting preoperative measurements and visual outcomes.

• 2

  PFHO treatment did not negatively affect refractive outcomes, with 82.6% of patients achieving predicted manifest refraction after therapy.

• 3

  Clinical signs of dry eye improved significantly, with total corneal fluorescein staining decreasing from 5.0 to 1.3 after PFHO therapy.

• 4

  Postoperative best-corrected visual acuity improved, with 92% of patients achieving 20/20 vision or better after continued PFHO treatment.

• 5

  Aggressive treatment of dry eye with PFHO enhances patient comfort and surgical outcomes without compromising refractive accuracy.